Sweden · Delayed Price · Currency is SEK Mycronic AB Statistics
Total Valuation
Mycronic AB has a market cap or net worth of SEK 58.04 billion. The enterprise value is 55.19 billion.
| Market Cap | 58.04B |
| Enterprise Value | 55.19B |
Important Dates
The last earnings date was Thursday, October 22, 2026.
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Mycronic AB has 195.29 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 195.29M |
| Shares Outstanding | 195.29M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 53.49% |
| Float | 150.39M |
Valuation Ratios
The trailing PE ratio is 29.17 and the forward PE ratio is 32.23. Mycronic AB's PEG ratio is 2.05.
| PE Ratio | 29.17 |
| Forward PE | 32.23 |
| PS Ratio | 6.21 |
| PB Ratio | 6.79 |
| P/TBV Ratio | 12.52 |
| P/FCF Ratio | 25.90 |
| P/OCF Ratio | 23.93 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.96, with an EV/FCF ratio of 24.62.
| EV / Earnings | 27.57 |
| EV / Sales | 5.90 |
| EV / EBITDA | 17.96 |
| EV / EBIT | 20.06 |
| EV / FCF | 24.62 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.28 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.19 |
| Interest Coverage | 51.60 |
Financial Efficiency
Return on equity (ROE) is 25.74% and return on invested capital (ROIC) is 37.71%.
| Return on Equity (ROE) | 25.74% |
| Return on Assets (ROA) | 14.33% |
| Return on Invested Capital (ROIC) | 37.71% |
| Return on Capital Employed (ROCE) | 28.22% |
| Weighted Average Cost of Capital (WACC) | 7.92% |
| Revenue Per Employee | 3.23M |
| Profits Per Employee | 692,174 |
| Employee Count | 2,875 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, Mycronic AB has paid 573.00 million in taxes.
| Income Tax | 573.00M |
| Effective Tax Rate | 22.37% |
Stock Price Statistics
The stock price has increased by +31.88% in the last 52 weeks. The beta is 0.66, so Mycronic AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +31.88% |
| 50-Day Moving Average | 321.53 |
| 200-Day Moving Average | 282.44 |
| Relative Strength Index (RSI) | 37.82 |
| Average Volume (20 Days) | 343,852 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mycronic AB had revenue of SEK 9.30 billion and earned 1.99 billion in profits. Earnings per share was 10.19.
| Revenue | 9.30B |
| Gross Profit | 5.10B |
| Operating Income | 2.74B |
| Pretax Income | 2.56B |
| Net Income | 1.99B |
| EBITDA | 2.96B |
| EBIT | 2.74B |
| Earnings Per Share (EPS) | 10.19 |
Balance Sheet
The company has 3.27 billion in cash and 415.00 million in debt, with a net cash position of 2.86 billion or 14.62 per share.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 415.00M |
| Net Cash | 2.86B |
| Net Cash Per Share | 14.62 |
| Equity (Book Value) | 8.50B |
| Book Value Per Share | 43.53 |
| Working Capital | 4.55B |
Cash Flow
In the last 12 months, operating cash flow was 2.41 billion and capital expenditures -183.00 million, giving a free cash flow of 2.23 billion.
| Operating Cash Flow | 2.41B |
| Capital Expenditures | -183.00M |
| Depreciation & Amortization | 227.00M |
| Net Borrowing | -109.00M |
| Free Cash Flow | 2.23B |
| FCF Per Share | 11.41 |
Margins
Gross margin is 54.88%, with operating and profit margins of 29.42% and 21.40%.
| Gross Margin | 54.88% |
| Operating Margin | 29.42% |
| Pretax Margin | 27.55% |
| Profit Margin | 21.40% |
| EBITDA Margin | 31.86% |
| EBIT Margin | 29.42% |
| FCF Margin | 23.98% |
Dividends & Yields
This stock pays an annual dividend of 3.25, which amounts to a dividend yield of 1.09%.
| Dividend Per Share | 3.25 |
| Dividend Yield | 1.09% |
| Dividend Growth (YoY) | -13.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 31.96% |
| FCF Payout Ratio | 28.47% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.10% |
| Earnings Yield | 3.43% |
| FCF Yield | 3.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Mycronic AB is 319.00, which is 7.34% higher than the current price. The consensus rating is "Hold".
| Price Target | 319.00 |
| Price Target Difference | 7.34% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 13.34% |
| EPS Growth Forecast (3Y) | 18.91% |
Stock Splits
The last stock split was on June 3, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jun 3, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |